Article
All buy-sell plans should cover the possibility of disability of one of the partners-the odds of disability before age 65 are much higher than the odds of death.
Advanced therapies for retinal vascular diseases
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
4DMT publishes preclinical data demonstrating the potential of the Therapeutic Vector Evolution (TVE) platform
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Study validates long-term efficacy of MicroPulse TLT for glaucoma management
Glaucoma 360 offering cutting-edge innovations and networking opportunities